Bionovate Technologies Corp
BIIO
$0.0001
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 43.18% | -73.65% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 43.18% | -73.65% | |||
| Operating Income | -43.18% | 73.65% | |||
| Income Before Tax | -10.20% | 38.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.20% | 38.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.20% | 38.17% | |||
| EBIT | -43.18% | 73.65% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -154.55% | -57.14% | |||
| Normalized Basic EPS | -142.86% | -75.00% | |||
| EPS Diluted | -154.55% | -57.14% | |||
| Normalized Diluted EPS | -142.86% | -75.00% | |||
| Average Basic Shares Outstanding | -57.63% | -59.87% | |||
| Average Diluted Shares Outstanding | -57.63% | -59.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||